Metagenomics Market Growth | Global Analysis 2027

Metagenomics Market to 2027 - Global Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Geography

Publication Month: Jan 2019 | Report Code: TIPRE00002997 | No. of Pages: 139 | Category: Biotechnology | Status: Published

The metagenomics market was valued at US$ 165.8 million in 2018 and it is projected to reach US$ 314.3 million in 2027; it is expected to grow at a CAGR of 7.7% from 2019 to 2027.

Metagenomics can be defined as the study of the metagenome, which is collective genome of microorganisms. The microorganisms are collected from an environmental samples and the studies are conducted to provide information on the microbial diversity and ecology of a specific environment. The study of microorganism is conducted through the shotgun metagenomics technology/ technique which is used to extract the DNA from the environmental sample and sequence the small fragments. The metagenomic is the rising and vibrant field that has appropriated the tools used for standard genomics and applied for the study of the entire communities of microbes. This requires no need to isolate and culture the individual microbial species. The primary aim of the metagenomics is study and identify the genes and metabolic pathways present in the microbial species. The growth of the global metagenomics market is attributed to the increasing venture capital investments, advantages of metagenomics in biotechnology and industrial application of metagenomics. However, high capital cost of metagenomics is the major factor hindering the market growth.

The global metagenomics market is expected to witness substantial growth The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Global Metagenomics Market



Lucrative Regions for Global Metagenomics Market

Get more information on this report :


Market Insights

Advantages of Metagenomics in Biotechnology to Drive Global Metagenomics Market Growth

Metagenomic is a field that combines various important molecular technologies and enables scientists to investigate microorganisms more deeply. The technology enables to unlock the vast biotechnological potentials that are held inside the microorganisms. Metagenomics helps to identify microorganism irrespective of whether they can be cultured or not. The analysis can be done from the genomic data obtained directly from an environmental sample that provides information about the species existing and it also allow the extraction of information regarding the functionality of microbial communities in their natural habitat.

In addition, the metagenomics also holds the capabilities in the food and pharmaceutical industries. For instance, metagenomics can be useful for the identification of enzymes with desirable technological properties. This enables to relate the capable of catalyzing novel reactions which may be difficult or expensive to produce. Moreover, it enables to identify the functions under a wide range of environmental conditions encountered in food and pharmaceutical processing cycles including extreme conditions of temperature, pH, osmolarity and others.

Furthermore, the biotechnological applications from metagenomics is likely to foster by the pursuit of fundamental ecological studies and focused screens for bioprospecting. Metagenomics has contributed to the discovery of antibiotics and industrial enzymes from cultured microorganisms. For instance, the discovery of streptomycin and other bacterial antibiotics bounced from very basic studies of metagenomics.

Therefore, owing to the advantages of the metagenomics for the application in biotechnologies are likely to boost the growth of the metagenomics market in the forecast years.

Product-Based Insights

In terms of product, the global metagenomics market is segmented into instruments & software and consumables. In 2018, the consumables segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.

Global Metagenomics Market, by Product – 2018 and 2027



Global Metagenomics Market, by Product – 2018 and 2027

Get more information on this report :


Application-Based Insights

In terms of application, the global metagenomics market is segmented into clinical diagnostic, drug discovery metagenomics and others. The clinical diagnostics segment held the largest share of the market in 2018 and the same segment is estimated to register the highest CAGR during the forecast period.

Strategic Insights

The global metagenomics market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Global Metagenomics Market – by Product

  • Instruments & Software
  • Consumables

Global Metagenomics Market – by Application

  • Clinical Diagnostics
  • Drug Discovery
  • Others

Global Metagenomics Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc
  • Perkinelmer Inc.
  • Illumina Inc.
  • F.Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.

Frequently Asked Questions

Metagenomics can be defined as the study of the metagenome, which is collective genome of microorganisms. The microorganisms’ samples are collected from environmental and the studies are performed to provide information on the microbial diversity and ecology of a specific environment. The study of microorganism is conducted through the shotgun technique, which is used to extract the DNA from the environmental sample and sequence the small fragments.
The growth of the global metagenomics market is attributed to the increasing venture capital investments, advantages of metagenomics in biotechnology and industrial application of metagenomics.
The most lucrative region is North America, growing at CAGR of 8%.
High capital cost of metagenomics is the major factor hindering the market growth.
The global metagenomics market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

TABLE OF CONTENTS

1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. GLOBAL METAGENOMICS MARKET – KEY TAKEAWAYS

3. GLOBAL METAGENOMICS MARKET – MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 Global Metagenomics Market – By Product
3.2.2 Global Metagenomics Market – By Application
3.2.3 Global Metagenomics Market – By Geography
3.3 PEST ANALYSIS
3.3.1 North America – PEST Analysis
3.3.2 Europe– PEST Analysis
3.3.3 Asia Pacific– PEST Analysis
3.3.4 Middle East And Africa– PEST Analysis
3.3.5 South and Central America – PEST Analysis

4. GLOBAL METAGENOMICS MARKET – KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increasing Venture Capital Investments
4.1.2 Advantages of Metagenomics in Biotechnology
4.1.3 Industrial Applications of Metagenomics
4.2 KEY MARKET RESTRAINTS
4.2.1 High Capital Costs Of Metagenomics
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Usage of Metagenomics for Precision Medicine
4.3.2 Emerging Nations
4.4 KEY MARKET TRENDS
4.4.1 Extensive Set Of Molecular-Based Approaches
4.5 IMPACT ANALYSIS

5. METAGENOMICS MARKET – GLOBAL ANALYSIS
5.1 GLOBAL METAGENOMICS MARKET REVENUE FORECASTS AND ANALYSIS
5.2 GLOBAL METAGENOMICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
5.3 MARKET POSITIONING
5.4 PERFORMANCE OF KEY PLAYERS
5.4.1 Illumina, Inc.
5.4.2 Qiagen
5.5 EXPERT OPINIONS

6. GLOBAL METAGENOMICS MARKET ANALYSIS – BY PRODUCT
6.1 OVERVIEW
6.2 GLOBAL METAGENOMICS MARKET, BY PRODUCT, 2018 & 2027 (%)
6.3 INSTRUMENTS & SOFTWARE MARKET
6.3.1 Overview
6.3.2 Global Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 CONSUMABLES MARKET
6.4.1 Overview
6.4.2 Global Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

7. GLOBAL METAGENOMICS MARKET ANALYSIS – BY APPLICATION
7.1 OVERVIEW
7.2 GLOBAL METAGENOMICS MARKET, BY APPLICATION, 2018 & 2027 (%)
7.3 CLINICAL DIAGNOSTIC MARKET
7.3.1 Overview
7.3.2 Global Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 DRUG DISCOVERY METAGENOMICS MARKET
7.4.1 Overview
7.4.2 Global Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 OTHERS MARKET
7.5.1 Overview
7.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
8.1 OVERVIEW
8.2 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
8.4 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
8.5 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
8.6 US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.1 US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.3 US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.7 CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7.1 Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.3 Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.8 MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.1 Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.3 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
9.1 OVERVIEW
9.2 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.3 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
9.4 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
9.5 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
9.6 UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.6.1 UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.6.2 UK Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.6.3 UK Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.7 GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.7.1 Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.7.2 Germany Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.7.3 Germany Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.8 FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.8.1 France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.8.2 France Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.8.3 France Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 70
10.1 OVERVIEW
10.2 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.3 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
10.4 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
10.5 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
10.6 CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.6.1 China Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.2 China Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.3 China Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.7 JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.7.1 Japan Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.2 Japan Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.3 Japan Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.8 INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.8.1 India Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2 India Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.3 India Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

11. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
11.1 OVERVIEW
11.2 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.3 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
11.4 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
11.5 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
11.6 UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.6.1 UAE Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.2 UAE Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.6.3 UAE Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.7 SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.7.1 Saudi Arabia Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.7.2 Saudi Arabia Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.7.3 Saudi Arabia Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.8 SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.8.1 South Africa Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.8.2 South Africa Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.8.3 South Africa Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

12. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
12.1 OVERVIEW
12.2 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.3 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
12.4 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
12.5 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
12.6 BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.6.1 Brazil Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
12.6.2 Brazil Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
12.6.3 Brazil Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

13. METAGENOMICS MARKET –INDUSTRY LANDSCAPE
13.1 OVERVIEW
13.2 GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.3 ORGANIC DEVELOPMENTS
13.3.1 Overview
13.4 ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.5 PRODUCT LAUNCH
13.5.1 Recent Product Launch By Players In The Metagenomics Market
13.6 PRODUCT APPROVAL
13.6.1 Recent Product Approval By Players In The Metagenomics Market
13.7 EXPANSION & OTHERS
13.7.1 The Metagenomics Market By Expansion & Other Growth Strategies
13.8 INORGANIC DEVELOPMENTS
13.8.1 Overview
13.9 INORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.10 ACQUISITIONS
13.10.1 Acquisitions By Players In The Metagenomics Market
13.11 AGREEMENTS
13.11.1 The Metagenomics Market By Agreements
13.12 PARTNERSHIP & COLLABORATION
13.12.1 Partnership By Players In The Metagenomics Market

14. METAGENOMICS MARKET–KEY COMPANY PROFILES
14.1 MERCK KGAA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 THERMO FISHER SCIENTIFIC, INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Information
14.2.4 Product Portfolio
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 AGILENT TECHNOLOGIES, INC.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 QIAGEN
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES, INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Information
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 PERKIN ELMER, INC.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ILLUMINA, INC.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 OXFORD NANOPORE TECHNOLOGIES LTD.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product & Services Portfolio
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 PACIFIC BIOSCIENCE OF CALIFORNIA, INC.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product & Services Portfolio
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 ABOUT THE INSIGHT PARTNERS
15.2 GLOSSARY OF TERMS
15.3 METHODOLOGY
15.3.1 Coverage
15.3.2 Secondary Research
15.3.3 Primary Research

LIST OF TABLES

TABLE 1. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 2. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 3. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 4. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 5. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 6. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 7. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 8. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 9. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 10. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 11. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 12. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 13. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 14. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 15. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 16. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 17. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 18. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 19. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 20. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 21. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 22. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 23. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 24. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 25. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 26. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 27. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 28. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 29. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 30. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 31. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 32. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 33. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 34. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 35. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 36. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 37. RECENT PRODUCT LAUNCH IN THE METAGENOMICS MARKET
TABLE 38. RECENT PRODUCT APPROVAL AND ENHANCEMENTS IN THE METAGENOMICS MARKET
TABLE 39. THE METAGENOMICS MARKET BY EXANSION & OTHERS STRATEGIES
TABLE 40. ACQUISITIONS IN THE METAGENOMICS MARKET
TABLE 41. THE METAGENOMICS MARKET BY AGREEMENTS
TABLE 42. PARTNERSHIP IN THE METAGENOMICS MARKET
TABLE 43. GLOSSARY OF TERMS, METAGENOMICS MARKET

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC METAGENOMICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
FIGURE 2. GLOBAL METAGENOMICS MARKET BY PRODUCT, MARKET SHARE (%), 2018
FIGURE 3. GLOBAL METAGENOMICS MARKET BY APPLICATION, MARKET SHARE (%), 2018
FIGURE 4. METAGENOMICS MARKET SEGMENTATION
FIGURE 5. METAGENOMICS SEGMENTATION, BY REGION
FIGURE 6. NORTH AMERICA PEST ANALYSIS
FIGURE 7. EUROPE PEST ANALYSIS
FIGURE 8. ASIA PACIFIC PEST ANALYSIS
FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
FIGURE 11. METAGENOMICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 12. GLOBAL METAGENOMICS MARKET – REVENUE FORECASTS AND ANALYSIS – 2018- 2027
FIGURE 13. GLOBAL METAGENOMICS MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2018- 2027
FIGURE 14. GLOBAL METAGENOMICS MARKET BY PRODUCT, 2018 & 2027 (%)
FIGURE 15. GLOBAL INSTRUMENTS & SOFTWARE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. GLOBAL CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. GLOBAL METAGENOMICS MARKET BY APPLICATION, 2018 & 2027 (%)
FIGURE 18. GLOBAL CLINICAL DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. GLOBAL DRUG DISCOVERY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 20. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. NORTH AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 22. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 24. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 27. EUROPE METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 28. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 29. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 30. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 31. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 32. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 33. ASIA PACIFIC METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 34. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 35. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 36. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 37. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 38. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 39. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 40. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 41. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 42. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 43. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 44. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 45. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 46. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 47. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 48. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 49. GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
FIGURE 50. ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
FIGURE 51. INORGANIC DEVELOPMENTS IN THE METAGENOMICS MARKET, 2015-2018

The List of Companies

1. Merck KGaA
2. Thermo Fisher Scientific Inc.
3. Agilent Technologies
4. Qiagen
5. Bio-Rad Laboratories, Inc.
6. Perkinelmer Inc.
7. Illumina Inc.
8. F Hoffman-La Roche Ltd.
9. Oxford Nanopore Technologies Ltd.
10. Pacific Bioscience of California, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00002997
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount